Taek Kwan KWON,Kwang Young LEE,Ho Taek IM,Yong Il KIM,Jae Hyun PARK,Jong Soo WOO
申请号：
US16319161
公开号：
US20190240209A1
申请日:
2017.07.24
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed is a pharmaceutical formulation containing esomeprazole or a pharmaceutically acceptable salt thereof. The pharmaceutical formulation, based on considerably improved pH-dependent drug release characteristics, starts to release the esomeprazole or a pharmaceutically acceptable salt thereof at a target delay time after oral administration, continues the release for a predetermined time, and finishes the release after a predetermined time, thereby providing excellent patient convenience and excellent therapeutic effects, as compared to conventional other formulations.
